Mark D. King

2.9k citations
18 papers · 2.2k · 2 hit papers · h-index 13

Impact in

    • Bacterial Identification and Susceptibility Testing
    • Antimicrobial Resistance in Staphylococcus
    • Tuberculosis Research and Epidemiology
    • Clostridium difficile and Clostridium perfringens research

Papers in

    • Antimicrobial Resistance in Staphylococcus 5
    • Tuberculosis Research and Epidemiology 2
    • Bacterial Identification and Susceptibility Testing 6
    • Metabolism and Genetic Disorders 1

Mark D. King

18 papers receiving 2.1k citations

Mark D. King's Hit Papers

Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections 2006 · 623 citations
6230+6+13Years since publication200400600

Peers

Mark D. King
Comparison fields: 5 of 112
  • Clinical Biochemistry 916
  • Infectious Diseases 1.6k
  • Applied Microbiology and Biotechnology 163
  • Molecular Medicine 174
  • Public Health, Environmental and Occupational Health 590
Replace Christopher J. Graber with:
Christopher J. Graber United States
Laurie Thomson Sanza United States
Kathleen Riederer United States
Samantha J. Eells United States
Magnus Arpi Denmark
Kathryn Como‐Sabetti United States
Wendy Munckhof Australia
Laurence Senn Switzerland
Elizabeth A. Grabsch Australia
Peter K. Linden United States
Mark D. King relative to Christopher J. Graber United States Christopher J. Graber's profile →
Citations per field
00.5×1.7×
Christopher J. Graber · 1×
Citations per year

Countries citing papers authored by Mark D. King

Since Specialization
Citations

This map shows the geographic impact of Mark D. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. King more than expected).

Fields of papers citing papers by Mark D. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. King. The network helps show where Mark D. King may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark D. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark D. King Line = papers co-authored together Mark D. King links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1
Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections
Hit paper breakdown →
2006623
2
Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream Infections
Hit paper breakdown →
2006549
3 2005272
4 2005156
5 2002146
6 2009108
7 2002105
8 200670
9 200259
10 201035
11 200333
12 200422
13 200415
14 20049
15 20038
16 20108
17 20052
18 20091

About Mark D. King

Mark D. King is a scholar working on Infectious Diseases, Clinical Biochemistry, Epidemiology, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 18 papers that have together received 2.2k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Streptococcal Infections and Treatments (3 papers), Tuberculosis Research and Epidemiology (2 papers), Antibiotic Use and Resistance (2 papers), Metabolism and Genetic Disorders (1 paper) and Oral and gingival health research (1 paper). The work is most often cited by research in Clinical Biochemistry (916 citations), Infectious Diseases (1.6k citations), Applied Microbiology and Biotechnology (163 citations), Molecular Medicine (174 citations) and Public Health, Environmental and Occupational Health (590 citations). Mark D. King has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Ekaterina V. Kourbatova, Henry M. Blumberg, Susan M. Ray, Yun F. Wang, Ulrich Seybold, H. M. Blumberg, Jeremiah G. Johnson, J. Sue Halvosa, Alicia Hidrón and Linda K. McDougal. Their work appears in journals such as Clinical Infectious Diseases, Annals of Internal Medicine, Neuropediatrics, International Journal of STD & AIDS and Journal of Investigative Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact